Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA AG    MRK   DE0006599905

MERCK KGAA AG

(MRK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

The $280,000 lab-grown burger could be a more palatable $10 in two years

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/10/2019 | 04:31am EDT
Mercedes Vila, co-founder of Biotech Foods, works in the company's laboratory in San Sebastian

(This July 9 story corrects to change company name to Biotech Foods in paragraph five.)

By Andrés González and Silke Koltrowitz

Consumers concerned about climate change, animal welfare and their own health are fueling interest in so-called clean meat, with the number of associated business start-ups climbing from four at the end of 2016 to more than two dozen two years later, according to the Good Food Institute market researcher.

Plant-based meat alternatives are also booming. Shares in Beyond Meat have more than tripled in price since its initial public offering in May. Beyond Meat and Impossible Foods each sell 100% plant-based meat alternatives to retailers and fast food chains across the United States.

And cultured meat grown from animal cells could be next on the mainstream menu, with producers eyeing regulatory approval as they improve the technology and reduce costs.

It was Dutch start-up Mosa Meat's co-founder Mark Post who created the first "cultured" beef hamburger in 2013 at a cost of 250,000 euros ($280,400), funded by Google co-founder Sergey Brin, but Mosa Meat and Spain's Biotech Foods say that production costs have fallen dramatically since then.

"The burger was this expensive in 2013 because back then it was novel science and we were producing at very small scale. Once production is scaled up, we project the cost of producing a hamburger will be around 9 euros," a Mosa Meat spokeswoman told Reuters, adding that it could ultimately become even cheaper than a conventional hamburger.

PRICE PARITY

Biotech Foods co-founder Mercedes Vila also highlighted the importance of moving from lab to factory.

"Our goal is to reach production scale and have regulatory approval by 2021," Vila said.

She said the average cost of producing a kilogram of cultured meat is now about 100 euros, significantly below the $800 cited a year ago by Future Meat Technologies, an Israeli biotech company that has received funding from U.S. meat processor Tyson Foods.

Biotech Foods, Mosa Meat and Higher Steaks, a London-based competitor also contacted by Reuters, have yet to file applications for EU approval because they are still working to improve their growth serum.

To make cultured meat, stem cells from the muscle of an animal are placed in a culture medium that is then put in a bioreactor - similar to those used for fermentation of beer and yogurt - to support growth of new strands of muscle tissue.

Liz Specht, associate director at the Good Food Institute market research firm that focuses on meat alternatives, said in a white paper this year that it was likely that cell-based meat would achieve price parity with conventional meat once production is on an industrial scale.

Specht identified the cell culture medium as the most significant cost driver and said it was possible to produce it without animal-derived components and at much lower prices.

ENERGY EFFICIENCY

Proponents of this new technology say it's the only environmentally sustainable way to satisfy meat demand that the United Nations' Food and Agriculture Organization expects to double between 2000 and 2050.

But John Lynch, an environmental scientist at the University of Oxford, said it remains unclear whether scalable lab-grown meat production can really convert energy and nutrients into meat more efficiently than conventional meat production.

"Some studies have suggested that cultured meat may require less of a 'feed' source than conventional livestock production, but require more energy. If this is the case, then their impact on the climate will depend on where this energy comes from," he said.

Interest in the category has ensured start-ups have had ample access to funding.

Biotech Foods' Vila said the company had sufficient funds up to 2021, the year it hopes to generate its first revenue, thanks to a capital injection from an unidentified investor.

Mosa Meat has meat processors Bell Food Group and Merck KGaA's venture capital arm M Ventures among its investors.

In May food and agriculture group Cargill announced it had invested in cultured meat company Aleph Farms.

(Reporting by Andres Gonzales in Madrid and Silke Koltrowitz in Zurich; Editing by David Goodman)

Stocks mentioned in the article
ChangeLast1st jan.
BELL FOOD GROUP AG -1.09% 272.5 Delayed Quote.-9.67%
BEYOND MEAT INC 9.85% 194.2 Delayed Quote.0.00%
FEEDER CATTLE?FUTURES (GF) - CMG (ELECTRONIC)/C1 0.07% 142.275 End-of-day quote.-5.96%
LIVE CATTLE (LE) - CMG (ELECTRONIC)/C1 0.02% 108.475 End-of-day quote.-13.78%
MERCK KGAA AG 1.09% 94.44 Delayed Quote.4.96%
TYSON FOODS 0.66% 81.33 Delayed Quote.51.31%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA AG
07/22MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
07/18Germany's Merck, Broad Institute Agree on Crispr Intellectual Property Licens..
DJ
07/18MERCK : Darmstadt, Germany and Broad Institute Announce CRISPR License Framework..
PU
07/18MERCK : Intermolecular stockholders approve acquisition by Merck KGaA, Darmstadt..
PU
07/18Intermolecular Stockholders Agree to Merck KGaA Acquisition
DJ
07/17MERCK : EMD Serono's Embracing Carers Launches 'Time Counts' to Raise 1 Million ..
AQ
07/16MERCK : Darmstadt, Germany's Embracing Carers™ Launches ‘Time Counts..
PU
07/16TRACKINSIGHT : No limit! S&P500, DJIA and Nasdaq Composite hitting new highs
TI
07/10The $280,000 lab-grown burger could be a more palatable $10 in two years
RE
07/09Health Care Up as Trump's Drug-Price Disclosure Rule Blocked - Health Care Ro..
DJ
More news
Financials (EUR)
Sales 2019 15 653 M
EBIT 2019 2 279 M
Net income 2019 1 545 M
Debt 2019 5 243 M
Yield 2019 1,41%
P/E ratio 2019 26,7x
P/E ratio 2020 21,8x
EV / Sales2019 2,96x
EV / Sales2020 2,77x
Capitalization 41 087 M
Chart MERCK KGAA AG
Duration : Period :
Merck KGaA AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 102,52  €
Last Close Price 94,50  €
Spread / Highest target 29,1%
Spread / Average Target 8,49%
Spread / Lowest Target -13,2%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA AG4.96%46 097
WUXI APPTEC CO LTD21.47%15 424
KYOWA HAKKO KIRIN CO LTD-9.23%9 168
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD18.62%8 909
JAZZ PHARMACEUTICALS PLC7.82%7 738
BETTA PHARMACEUTICALS CO LTD--.--%2 712